FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF U.A. purchased 23.5% of their position (470.63K shares) of ENGENE THERAPEUTICS INC. on the open market
Open‑market purchase worth $3.01M — a significant purchase. The strongest form of insider conviction signal.
Common Shares
Shares
+2.75K
Price / share
$7.17
Trade value
$19.71K
% of position
Common Shares
Shares
+5.05K
Price / share
$7.69
Trade value
$38.83K
% of position
Common Shares
Shares
+400.00
Price / share
$8.30
Trade value
$3.32K
% of position
Common Shares
Shares
+9.62K
Price / share
$9.09
Trade value
$87.45K
% of position
Common Shares
Shares
+38.40K
Price / share
$5.94
Trade value
$228.01K
% of position
Common Shares
Shares
+3.24K
Price / share
$6.38
Trade value
$20.69K
% of position
Common Shares
Shares
+341.33K
Price / share
$6.34
Trade value
$2.16M
% of position
Common Shares
Shares
+35.28K
Price / share
$6.44
Trade value
$227.16K
% of position
Common Shares
Shares
+10.15K
Price / share
$6.37
Trade value
$64.70K
% of position
Common Shares
Shares
+5.77K
Price / share
$6.48
Trade value
$37.40K
% of position
Common Shares
Shares
+6K
Price / share
$6.54
Trade value
$39.24K
% of position
Common Shares
Shares
+11.84K
Price / share
$6.55
Trade value
$77.53K
% of position
Common Shares
Shares
+800.00
Price / share
$6.60
Trade value
$5.28K
% of position
Net shares
+470.63K
Net value
$3.01M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 12/27/2023 | P · Purchase | +2.75K | $7.17 | $19.71K | 0.1% | 2M | 2M |
| Common Shares Direct | 12/28/2023 | P · Purchase | +5.05K | $7.69 | $38.83K | 0.3% | 2M | 2.01M |
| Common Shares Direct | 12/29/2023 | P · Purchase | +400.00 | $8.30 | $3.32K | 0.0% | 2.01M | 2.01M |
| Common Shares Direct | 12/29/2023 | P · Purchase | +9.62K | $9.09 | $87.45K | 0.5% | 2.01M | 2.02M |
| Common Shares Direct | 9/27/2024 | P · Purchase | +38.40K | $5.94 | $228.01K | 1.9% | 2.02M | 2.06M |
| Common Shares Direct | 9/27/2024 | P · Purchase | +3.24K | $6.38 | $20.69K | 0.2% | 2.06M | 2.06M |
| Common Shares Direct | 9/30/2024 | P · Purchase | +341.33K | $6.34 | $2.16M | 16.6% | 2.06M | 2.40M |
| Common Shares Direct | 10/1/2024 | P · Purchase | +35.28K | $6.44 | $227.16K | 1.5% | 2.40M | 2.44M |
| Common Shares Direct | 10/2/2024 | P · Purchase | +10.15K | $6.37 | $64.70K | 0.4% | 2.44M | 2.45M |
| Common Shares Direct | 10/3/2024 | P · Purchase | +5.77K | $6.48 | $37.40K | 0.2% | 2.45M | 2.45M |
| Common Shares Direct | 10/4/2024 | P · Purchase | +6K | $6.54 | $39.24K | 0.2% | 2.45M | 2.46M |
| Common Shares Direct | 10/7/2024 | P · Purchase | +11.84K | $6.55 | $77.53K | 0.5% | 2.46M | 2.47M |
| Common Shares Direct | 10/8/2024 | P · Purchase | +800.00 | $6.60 | $5.28K | 0.0% | 2.47M | 2.47M |
| Total | +470.63K | $3.01M | ||||||
Common Shares
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 3.77M | Indirect |
| Total | 3.77M | 3.77M indirect |